News Releases

BAUSCH HEALTH TO PARTICIPATE AT THE 40TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

LAVAL, QC, Jan. 5, 2022 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) today announced that Joseph C. Papa, chairman and chief executive officer, is scheduled to participate at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, Jan. 12, 2022 at 9:00 a.m. ET.

A live webcast and audio archive of the event will be available on the Investor Relations page of the Bausch Health Companies Inc. website at: https://ir.bauschhealth.com/events-and-presentations/2022.

About Bausch Health
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. For more information, visit www.bauschhealth.com and connect with us on Twitter and LinkedIn

Investor Contact:    




Media Contact:

Arthur Shannon




Lainie Keller

arthur.shannon@bauschhealth.com  




lainie.keller@bauschhealth.com

(514) 856-3855   




(908) 927-1198

(877) 281-6642 (toll free)     





 

Bausch Health logo (PRNewsfoto/Bausch Health Companies Inc.)

 

SOURCE Bausch Health Companies Inc.